Most noteworthy is the danger of eating charred or burnt food, which contain toxic compounds that can raise the chances of developing prostate, bowel and ultra-lethal pancreatic cancer.

Some patients with medullary thyroid cancers, pancreatic neuroendocrine tumors ... National Organization of Rare Disorders. Carcinoid syndrome. American Cancer Society. Tests for gastrointestinal ...

Clinical Director of the Gastrointestinal Cancer Center and Director of the Program in Carcinoid and Neuroendocrine Tumors at Dana-Farber Cancer Institute. "It was encouraging to see that ...

– FDA approval based on the phase 3 CABINET pivotal trial, which demonstrated a statistically significant and clinically meaningful improvement in progression-free survival versus placebo ...

“The characteristics of NET vary widely from patient to patient, and very few treatment options have demonstrated the ability to improve outcomes across such a heterogeneous population,” said Jennifer ...

Cancer advocates, researchers, clinicians and patients are speaking out in a new STAT News article published this week about the devastating impact the cuts to federal research funding will have on ...

CINCINNATI (WKRC) — Researchers are conducting a groundbreaking trial that could revolutionize the way the body fights cancer, particularly for those living with pancreatic cancer. This trial is ...

"Historically, we've known that KRAS mutations are associated with a more biologically aggressive pancreatic cancer," says Jennifer Leiting, M.D., hepatobiliary and pancreatic surgeon within Mayo ...

Pancreatic cancer remains one of the most formidable cancers due to its insidious nature. In its initial stages, it rarely causes noticeable symptoms, making early diagnosis incredibly challenging.

The research team found that not only was RAS(ON) multi-selective inhibition effective in preclinical pancreatic cancer models, but it was even more effective when combined with immunotherapy ...